Ocular Therapeutix (OCUL) Other Non-Current Assets (2013 - 2026)

Ocular Therapeutix has reported Other Non-Current Assets for 14 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (changed 0.0% YoY), and the FY2025 full-year result was $1.6 million, changed 0.0% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.6 million, roughly flat from $1.6 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.8 million in Q1 2022, with the low at $1.6 million in Q4 2023.
• Average Other Non-Current Assets over 5 years is $1.7 million, with a median of $1.6 million recorded in 2023.
• Year-over-year, Other Non-Current Assets changed 0.0% in 2022 and dropped 8.5% in 2023.
• Tracing OCUL's Other Non-Current Assets over 5 years: stood at $1.8 million in 2022, then retreated by 8.5% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison